BNGO logo

Bionano Genomics, Inc. (BNGO)

Profile

Full Name

Bionano Genomics, Inc.

Ticker

NASDAQ: BNGO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

August 21, 2018

Indexes

Not included

Website

https://bionano.com

Employees

98

Key Details

Price

$3.15(+3.62%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$30.78M(-14.79% YoY)

Annual EPS

-$88.13(-1194.15% YoY)

PE ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.15
    BNGO price is $3.15

    30-Day Relative Volume

    1.05
    BNGO 30-day relative volume is 1.05

    Price Performance

    Price Today change

    +3.62%
    BNGO price is up +3.62% today

    Price YTD change

    -81.9%
    BNGO price is down -81.9% since January 1st

    Price 1-year change

    -90.28%
    BNGO price is down -90.28% year-on-year

    Price 3-year change

    -99.82%
    BNGO price is down -99.82% over the past 3 years

    Price Range

    Price All-time high

    $9414.00
    BNGO price is currently -99.97% below its historical high of $9414.00

    Price 3-year low

    $2.68
    BNGO price is currently +17.54% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $10.60M
    BNGO market capitalization is $10.60 million

    Market cap 3-year change

    -98.74%
    BNGO market capitalization is down -98.74% over the past 3 years

    Market cap All-time high

    $2.96B
    BNGO market capitalization is currently -99.64% below its historical high of $2.96 billion

    Market cap sector rank

    16.75%
    BNGO market capitalization is higher than 16.75% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +134.7%
    BNGO shares outstanding is up +134.7% year-on-year

    Shares Outstanding 3-Year Change

    +595.62%
    BNGO shares outstanding is up +595.62% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.86
    BNGO beta is 0.86

    200-day SMA

    $6.96
    BNGO price is currently -54.77% below its 200-day simple moving average

    50-day SMA

    $3.31
    BNGO price is currently -4.70% below its 50-day simple moving average

    RSI

    48.51
    BNGO 14-day relative strength index is 48.51

    Volume

    1.05
    BNGO 30-day relative volume is 1.05

    ATR

    $0.14
    BNGO average true range is $0.14

    10-day Historical Volatility

    53.71%
    BNGO 10-day historical volatility is 53.71%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $30.78M
    BNGO annual revenue is $30.78 million

    Revenue Analysts estimate

    $28.98M
    BNGO annual revenue is currently +6.18% higher than the consensus analysts' forecast

    Revenue 1-year change

    -14.79%
    BNGO annual revenue is down -14.79% year-on-year

    Revenue Sector rank

    56.51%
    BNGO annual revenue is higher than 56.51% of companies in Healthcare sector

    EPS

    EPS

    -$88.13
    BNGO annual earnings per share is -$88.13

    EPS Analysts estimate

    -$5.59
    BNGO annual earnings per share is currently +1476.59% higher than the consensus analysts' forecast

    EPS 1-year change

    -1194.15%
    BNGO annual earnings per share is down -1194.15% year-on-year

    EPS Sector rank

    2.66%
    BNGO annual earnings per share is higher than 2.66% of companies in Healthcare sector

    Profit

    Gross profit

    $380.00K
    BNGO annual gross profit is $380.00 thousand

    Gross margin

    1.23%
    BNGO annual gross profit margin is 1.23%

    Operating profit

    -$76.28M
    BNGO annual operating income is -$76.28 million

    Operating margin

    -247.85%
    BNGO annual operating profit margin is -247.85%

    Net income

    -$112.02M
    BNGO annual net profit is -$112.02 million

    Net margin

    -363.98%
    BNGO annual net profit margin is -363.98%

    Expenses

    Total expenses

    $107.05M
    BNGO annual total expenses is $107.05 million

    Operating expenses

    $76.66M
    BNGO annual total operating expenses is $76.66 million

    Cost of goods sold

    $30.40M
    BNGO annual cost of goods sold is $30.40 million

    Selling, general & administrative expenses

    $51.85M
    BNGO annual SGA is $51.85 million

    Depreciation and amortization

    $14.23M
    BNGO annual depreciation & amortization is $14.23 million

    Interest expense

    $289.00K
    BNGO annual interest expense is $289.00 thousand

    Income tax

    $33.00K
    BNGO annual income tax is $33.00 thousand

    EBIT & EBITDA

    EBIT

    -$111.69M
    BNGO annual earnings before interest & taxes is -$111.69 million

    EBITDA

    -$97.47M
    BNGO annual EBITDA is -$97.47 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $76.67M
    BNGO annual total assets is $76.67 million

    Non current assets

    $37.18M
    BNGO annual long term assets is $37.18 million

    Current assets

    $39.49M
    BNGO annual total current assets is $39.49 million

    Cash and cash equivalents

    $9.17M
    BNGO annual cash & cash equivalents is $9.17 million

    Accounts receivable

    $4.75M
    BNGO annual accounts receivable is $4.75 million

    Inventory

    $11.12M
    BNGO annual inventory is $11.12 million

    Liabilities

    Total liabilities

    $41.30M
    BNGO annual total liabilities is $41.30 million

    Long term liabilities

    $3.95M
    BNGO annual total long term liabilities is $3.95 million

    Current liabilities

    $37.34M
    BNGO annual total current liabilities is $37.34 million

    Accounts payable

    $6.96M
    BNGO annual accounts payable is $6.96 million

    Debt

    Total debt

    $6.93M
    BNGO annual total debt is $6.93 million

    Total debt 1-year change

    -27.84%
    BNGO annual total debt is down -27.84% year-on-year

    Long term debt

    $3.68M
    BNGO annual long term debt is $3.68 million

    Short term debt

    $3.25M
    BNGO annual short term debt is $3.25 million

    Equity & Capital

    Shareholders equity

    $35.38M
    BNGO annual stockholders equity is $35.38 million

    Book value

    $35.38M
    BNGO annual book value is $35.38 million

    Retained earnings

    -$693.23M
    BNGO annual retained earnings is -$693.23 million

    Working capital

    $2.15M
    BNGO annual working capital is $2.15 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$68.92M
    BNGO annual cash flow from operations is -$68.92 million

    Cash from operations 1-year change

    +44.94%
    BNGO annual cash flow from operations is up +44.94% year-on-year

    Cash from investing

    $73.84M
    BNGO annual cash flow from investing activities is $73.84 million

    Cash from investing 1-year change

    +205.65%
    BNGO annual cash flow from investing activities is up +205.65% year-on-year

    Cash from financing

    -$13.69M
    BNGO annual cash flow from financing activities is -$13.69 million

    Cash from financing 1-year change

    -112.02%
    BNGO annual cash flow from financing activities is down -112.02% year-on-year

    CAPEX

    CAPEX

    $103.00K
    BNGO annual capital expenditures is $103.00 thousand

    CAPEX 1-year change

    -93.91%
    BNGO annual capital expenditures is down -93.91% year-on-year

    Free Cash Flow

    Free cash flow

    -$69.03M
    BNGO annual free cash flow is -$69.03 million

    Free cash flow 1-year change

    +45.59%
    BNGO annual free cash flow is up +45.59% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    1.23%
    BNGO annual gross profit margin is 1.23%

    Operating margin

    -247.85%
    BNGO annual operating profit margin is -247.85%

    Net margin

    -363.98%
    BNGO annual net profit margin is -363.98%

    ROA & ROE

    ROA

    -76.97%
    BNGO annual return on assets is -76.97%

    ROE

    -170.33%
    BNGO annual return on equity is -170.33%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BNGO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BNGO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.23
    BNGO price to book ratio is 0.23

    PB ratio Sector rank

    20.12%
    BNGO price to book ratio is higher than 20.12% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.39
    BNGO price to sales ratio is 0.39

    PS ratio Sector rank

    11.17%
    BNGO price to sales ratio is higher than 11.17% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -$16.84M
    BNGO enterprise value is -$16.84 million

    Enterprise value Sector rank

    6.01%
    BNGO enterprise value is higher than 6.01% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.40
    BNGO EV/EBITDA is 0.40

    EV/EBITDA Sector rank

    69%
    BNGO EV/EBITDA is higher than 69% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.06
    BNGO annual current ratio is 1.06

    Quick ratio

    0.76
    BNGO annual quick ratio is 0.76

    Leverage

    Debt to equity

    0.00
    BNGO annual debt to equity ratio is 0.00

    Interest coverage ratio

    -386.49
    BNGO annual interest coverage ratio is -386.49

    Risk & Stability

    Piotroski F-Score

    -
    BNGO piotroski f-score value is unknown

    Altman Z-Score

    -16.88
    BNGO altman z-score is -16.88

    Analyst ratings

    Recent major analysts updates

    May 20, 25 Maxim Group
    Buy
    Apr 9, 25 HC Wainwright & Co.
    Buy
    Apr 2, 25 Scotiabank
    Sector Perform
    Nov 15, 24 Ladenburg Thalmann
    Neutral
    May 16, 24 BTIG
    Buy
    Mar 7, 24 Scotiabank
    Sector Outperform
    Nov 13, 23 Maxim Group
    Hold
    Aug 10, 23 BTIG
    Buy
    Jun 9, 23 BTIG
    Buy
    May 25, 23 EF Hutton
    Buy

    Institutional Ownership

    Screeners with BNGO included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Bionano Genomics, Inc.?
    • Does Bionano Genomics, Inc. pay dividends?
    • What sector is Bionano Genomics, Inc. in?
    • What industry is Bionano Genomics, Inc. in?
    • What country is Bionano Genomics, Inc. based in?
    • When did Bionano Genomics, Inc. go public?
    • Is Bionano Genomics, Inc. in the S&P 500?
    • Is Bionano Genomics, Inc. in the NASDAQ 100?
    • Is Bionano Genomics, Inc. in the Dow Jones?
    • When was Bionano Genomics, Inc.'s last earnings report?
    • When does Bionano Genomics, Inc. report earnings?

    What is the ticker symbol for Bionano Genomics, Inc.?

    The ticker symbol for Bionano Genomics, Inc. is NASDAQ:BNGO

    Does Bionano Genomics, Inc. pay dividends?

    No, Bionano Genomics, Inc. does not pay dividends

    What sector is Bionano Genomics, Inc. in?

    Bionano Genomics, Inc. is in the Healthcare sector

    What industry is Bionano Genomics, Inc. in?

    Bionano Genomics, Inc. is in the Medical Instruments & Supplies industry

    What country is Bionano Genomics, Inc. based in?

    Bionano Genomics, Inc. is headquartered in United States

    When did Bionano Genomics, Inc. go public?

    Bionano Genomics, Inc.'s initial public offering (IPO) was on August 21, 2018

    Is Bionano Genomics, Inc. in the S&P 500?

    No, Bionano Genomics, Inc. is not included in the S&P 500 index

    Is Bionano Genomics, Inc. in the NASDAQ 100?

    No, Bionano Genomics, Inc. is not included in the NASDAQ 100 index

    Is Bionano Genomics, Inc. in the Dow Jones?

    No, Bionano Genomics, Inc. is not included in the Dow Jones index

    When was Bionano Genomics, Inc.'s last earnings report?

    Bionano Genomics, Inc.'s most recent earnings report was on August 14, 2025

    When does Bionano Genomics, Inc. report earnings?

    The next expected earnings date for Bionano Genomics, Inc. is November 14, 2025
    On this page